These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 12548340

  • 1. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.
    Arabia G, Zappia M, Bosco D, Crescibene L, Bagalà A, Bastone L, Caracciolo M, Scornaienghi M, Quattrone A.
    Neurol Sci; 2002 Sep; 23 Suppl 2():S53-4. PubMed ID: 12548340
    [Abstract] [Full Text] [Related]

  • 2. Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?
    Martinelli P, Contin M, Scaglione C, Riva R, Albani F, Baruzzi A.
    Neurol Sci; 2003 Oct; 24(3):192-3. PubMed ID: 14598082
    [Abstract] [Full Text] [Related]

  • 3. Body weight influences pharmacokinetics of levodopa in Parkinson's disease.
    Zappia M, Crescibene L, Arabia G, Nicoletti G, Bagalà A, Bastone L, Caracciolo M, Bonavita S, Di Costanzo A, Scornaienchi M, Gambardella A, Quattrone A.
    Clin Neuropharmacol; 2002 Oct; 25(2):79-82. PubMed ID: 11981233
    [Abstract] [Full Text] [Related]

  • 4. Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade).
    Sharma JC, Macnamara L, Hasoon M, Vassallo M, Ross I.
    Parkinsonism Relat Disord; 2006 Dec; 12(8):499-505. PubMed ID: 16935018
    [Abstract] [Full Text] [Related]

  • 5. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 6. The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease.
    Walker RW, Howells AR, Gray WK.
    Parkinsonism Relat Disord; 2011 Jan; 17(1):27-9. PubMed ID: 21051272
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
    Contin M, Martinelli P, Mochi M, Riva R, Albani F, Baruzzi A.
    Mov Disord; 2005 Jun; 20(6):734-9. PubMed ID: 15747357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
    Muhlack S, Woitalla D, Welnic J, Twiehaus S, Przuntek H, Müller T.
    Neurosci Lett; 2004 Jun 17; 363(3):284-7. PubMed ID: 15182961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dyskinesia-induced postural instability in Parkinson's disease.
    Armand S, Landis T, Sztajzel R, Burkhard PR.
    Parkinsonism Relat Disord; 2009 Jun 17; 15(5):359-64. PubMed ID: 18851925
    [Abstract] [Full Text] [Related]

  • 12. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
    Katzenschlager R, Hughes A, Evans A, Manson AJ, Hoffman M, Swinn L, Watt H, Bhatia K, Quinn N, Lees AJ.
    Mov Disord; 2005 Feb 17; 20(2):151-7. PubMed ID: 15390035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight.
    Sharma JC, Ross IN, Rascol O, Brooks D.
    Eur J Neurol; 2008 May 17; 15(5):493-6. PubMed ID: 18355302
    [Abstract] [Full Text] [Related]

  • 15. The spectrum of levodopa-induced dyskinesias.
    Fahn S.
    Ann Neurol; 2000 Apr 17; 47(4 Suppl 1):S2-9; discussion S9-11. PubMed ID: 10762127
    [Abstract] [Full Text] [Related]

  • 16. Levodopa induced motor complications in Thai Parkinson's disease patients.
    Kulkantrakorn K, Tiamkao S, Pongchaiyakul C, Pulkes T.
    J Med Assoc Thai; 2006 May 17; 89(5):632-7. PubMed ID: 16756048
    [Abstract] [Full Text] [Related]

  • 17. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF, Gao J, Durairajan SS, Man SC, Xie LX, Lu JH, Fong WL, Li M.
    J Clin Neurosci; 2009 Aug 17; 16(8):1034-7. PubMed ID: 19428256
    [Abstract] [Full Text] [Related]

  • 18. Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson's disease.
    Nagayama H, Ueda M, Kumagai T, Tsukamoto K, Nishiyama Y, Nishimura S, Hamamoto M, Katayama Y.
    Parkinsonism Relat Disord; 2011 Mar 17; 17(3):150-2. PubMed ID: 21172738
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.